Literature DB >> 31869432

T cell reconstitution after lymphocyte depletion features a different pattern of inhibitory receptor expression in ABO- versus HLA-incompatible kidney transplant recipients.

A Del Bello1,2,3, N Kamar1,2,3, E Treiner2,3,4.   

Abstract

Chronic antigen stimulation can lead to immune exhaustion (a state of T cell dysfunction). Several phenotypical signatures of T cell exhaustion have been described in various pathological situations, characterized by aberrant expression of multiple inhibitory receptors (IR). This signature has been barely studied in the context of allogenic organ transplantation. We undertook a cross-sectional analysis of the expression of IR [CD244, CD279, T cell immunoreceptor with immunoglobulin (Ig) and immunoreceptor tyrosine-based inhibition motif (ITIM) domains (TIGIT) and CD57] and their correlation with cytokine-producing functions in T cells reconstituting after lymphocyte depletion in patients transplanted from living donors, with preformed donor-specific antibodies. After ABO incompatible transplantation, T cells progressively acquired a phenotype similar to healthy donors and the expression of several IR marked cells with increased functions, with the exception of TIGIT, which was associated with decreased cytokine production. In stark contrast, T cell reconstitution in patients with anti-human leukocyte antigen (HLA) antibodies was characterized with an increased co-expression of IR by T cells, and specifically by an increased expression of TIGIT. Furthermore, expression of these receptors was no longer directly correlated to cytokine production. These results suggest that T cell alloreactivity in HLA-incompatible kidney transplantation drives an aberrant T cell reconstitution with respect to IR profile, which could have an impact on the transplantation outcome.
© 2019 British Society for Immunology.

Entities:  

Keywords:  T cells; cytokines; donor-specific antibodies; graft rejection; immune exhaustion; inhibitory receptors; transplantation

Mesh:

Substances:

Year:  2020        PMID: 31869432      PMCID: PMC7066389          DOI: 10.1111/cei.13412

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  54 in total

1.  Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion.

Authors:  Jonathan P Pearl; Jeremy Parris; Douglas A Hale; Steven C Hoffmann; Wendy B Bernstein; Kelly L McCoy; S John Swanson; Roslyn B Mannon; Mario Roederer; Allan D Kirk
Journal:  Am J Transplant       Date:  2005-03       Impact factor: 8.086

2.  Endemic and opportunistic infections in Brazilian solid organ transplant recipients.

Authors:  M V Batista; L C Pierrotti; E Abdala; W T Clemente; E S Girão; D R T Rosa; L E Ianhez; P R Bonazzi; A S Lima; P F C B C Fernandes; M V Pádua-Neto; T Bacchella; A P P Oliveira; C F G Viana; M S Ferreira; M A Shikanai-Yasuda
Journal:  Trop Med Int Health       Date:  2011-06-21       Impact factor: 2.622

3.  TIGIT immune checkpoint blockade restores CD8+ T-cell immunity against multiple myeloma.

Authors:  Camille Guillerey; Heidi Harjunpää; Nadège Carrié; Sahar Kassem; Tricia Teo; Kim Miles; Sophie Krumeich; Marianne Weulersse; Marine Cuisinier; Kimberley Stannard; Yuan Yu; Simone A Minnie; Geoffrey R Hill; William C Dougall; Hervé Avet-Loiseau; Michele W L Teng; Kyohei Nakamura; Ludovic Martinet; Mark J Smyth
Journal:  Blood       Date:  2018-07-09       Impact factor: 22.113

4.  Tolerance induction to a mammalian blood group-like carbohydrate antigen by syngeneic lymphocytes expressing the antigen, II: tolerance induction on memory B cells.

Authors:  Muhammad M Mohiuddin; Haruko Ogawa; Deng-Ping Yin; Uri Galili
Journal:  Blood       Date:  2003-03-20       Impact factor: 22.113

Review 5.  Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease.

Authors:  John Attanasio; E John Wherry
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

Review 6.  Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.

Authors:  Ana C Anderson; Nicole Joller; Vijay K Kuchroo
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

7.  ABO-Incompatible Kidney Transplant Outcomes: A Meta-Analysis.

Authors:  Annelies E de Weerd; Michiel G H Betjes
Journal:  Clin J Am Soc Nephrol       Date:  2018-07-16       Impact factor: 8.237

8.  2B4 Mediates Inhibition of CD8+ T Cell Responses via Attenuation of Glycolysis and Cell Division.

Authors:  Sonia J Laurie; Danya Liu; Maylene E Wagener; Phoebe C Stark; Cox Terhorst; Mandy L Ford
Journal:  J Immunol       Date:  2018-07-16       Impact factor: 5.422

9.  TIGIT-Fc alleviates acute graft-versus-host disease by suppressing CTL activation via promoting the generation of immunoregulatory dendritic cells.

Authors:  Dongliang Zhang; Wei Hu; Jiangang Xie; Yuan Zhang; Bo Zhou; Xueqin Liu; Yun Zhang; Yingjun Su; Boquan Jin; Shuzhong Guo; Ran Zhuang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-06-28       Impact factor: 5.187

Review 10.  ABO-Incompatible Kidney Transplantation.

Authors:  Christian Morath; Martin Zeier; Bernd Döhler; Gerhard Opelz; Caner Süsal
Journal:  Front Immunol       Date:  2017-03-06       Impact factor: 7.561

View more
  2 in total

Review 1.  TIGIT as a Promising Therapeutic Target in Autoimmune Diseases.

Authors:  Chenran Yue; Sheng Gao; Shuting Li; Zhouhang Xing; Hengrong Qian; Ying Hu; Wenqian Wang; Chunyan Hua
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

2.  The CD226/TIGIT axis is involved in T cell hypo-responsiveness appearance in long-term kidney transplant recipients.

Authors:  Arnaud Del Bello; Anna Gouin; Camille Chaubet; Nassim Kamar; Emmanuel Treiner
Journal:  Sci Rep       Date:  2022-07-12       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.